by Ryan Young on December 18, 2013
in Health and Illness, Nanny State, Nano & Biotech, Podcast, Regulation
Have a listen here.
The Food and Drug Administration recently banned 23andMe, a genetic testing service, from marketing its product to consumers. CEI Executive Director and Senior Fellow Gregory Conko thinks the FDA should reverse the ban.
Comments on this entry are closed.
Previous post: IRS Threatens to Curb Criticism of IRS and Bureaucratic Wrongdoing by 501(c)(3) and 501(c)(4) Groups
Next post: Cataloging Washington’s Hidden Costs, Part 4: The Costs of Poor Regulatory Sausage Making